BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32634198)

  • 21. "I take my pills every day, but then it goes up, goes down. I don't know what's going on": Perceptions of HIV virological failure in a rural context in Mozambique. A qualitative research study.
    Pulido Tarquino IA; Venables E; de Amaral Fidelis JM; Giuliani R; Decroo T
    PLoS One; 2019; 14(6):e0218364. PubMed ID: 31206540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.
    Dave JA; Levitt NS; Ross IL; Lacerda M; Maartens G; Blom D
    PLoS One; 2016; 11(3):e0151911. PubMed ID: 26986065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Status of HIV-infections 2005].
    Potthoff A; Brockmeyer NH
    Herz; 2005 Sep; 30(6):451-7. PubMed ID: 16170674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research.
    Bloomfield GS; Khazanie P; Morris A; Rabadán-Diehl C; Benjamin LA; Murdoch D; Radcliff VS; Velazquez EJ; Hicks C
    J Acquir Immune Defic Syndr; 2014 Sep; 67 Suppl 1(0 1):S40-53. PubMed ID: 25117960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a Structured Pharmaceutical Care Intervention Versus Usual Care on Cardiovascular Risk in HIV Patients on Antiretroviral Therapy: INFAMERICA Study.
    Morillo-Verdugo R; Robustillo-Cortés MLA; Martín-Conde MT; Callejón-Callejón G; Cid-Silva P; Moriel-Sánchez C; Tortajada-Goitia B; Almeida-González CV
    Ann Pharmacother; 2018 Nov; 52(11):1098-1108. PubMed ID: 29808711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future challenges for clinical care of an ageing population infected with HIV: a modelling study.
    Smit M; Brinkman K; Geerlings S; Smit C; Thyagarajan K; Sighem Av; de Wolf F; Hallett TB;
    Lancet Infect Dis; 2015 Jul; 15(7):810-8. PubMed ID: 26070969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain.
    Estrada V; Bernardino JI; Masiá M; Iribarren JA; Ortega A; Lozano F; Miralles C; Olalla J; Santos J; Elías MJ; Domingo P; Cruz AF
    HIV Clin Trials; 2015; 16(2):57-65. PubMed ID: 25874992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting affect cardiovascular health in Indonesian HIV patients beginning ART.
    Karim B; Wijaya IP; Rahmaniyah R; Ariyanto I; Waters S; Estiasari R; Price P
    AIDS Res Ther; 2017 Aug; 14(1):52. PubMed ID: 28859681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique.
    Bila DC; Boullosa LT; Vubil AS; Mabunda NJ; Abreu CM; Ismael N; Jani IV; Tanuri A
    PLoS One; 2015; 10(7):e0130580. PubMed ID: 26151752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study.
    Chireshe R; Naidoo K; Nyamakura R
    Afr J Prim Health Care Fam Med; 2019 Aug; 11(1):e1-e8. PubMed ID: 31478742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular manifestations of HIV infection in children.
    Idris NS; Grobbee DE; Burgner D; Cheung MM; Kurniati N; Sastroasmoro S; Uiterwaal CS
    Eur J Prev Cardiol; 2015 Nov; 22(11):1452-61. PubMed ID: 25398702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of non-communicable diseases among key populations enrolled at a large HIV prevention & treatment program in Kenya.
    Achwoka D; Oyugi JO; Mutave R; Munywoki P; Achia T; Akolo M; Muriuki F; Muthui M; Kimani J
    PLoS One; 2020; 15(7):e0235606. PubMed ID: 32614906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends and risk factors for obesity among HIV positive Nigerians on antiretroviral therapy.
    Ezechi LO; Musa ZA; Otobo VO; Idigbe IE; Ezechi OC
    Ceylon Med J; 2016 Jun; 61(2):56-62. PubMed ID: 27423745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV and the body: a review of multidisciplinary management.
    Rockstroh J; Guaraldi G; Deray G
    HIV Med; 2010 Sep; 11 Suppl 2():1-8. PubMed ID: 20929492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
    Hermans LE; Moorhouse M; Carmona S; Grobbee DE; Hofstra LM; Richman DD; Tempelman HA; Venter WDF; Wensing AMJ
    Lancet Infect Dis; 2018 Feb; 18(2):188-197. PubMed ID: 29158101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors.
    Bakal DR; Coelho LE; Luz PM; Clark JL; De Boni RB; Cardoso SW; Veloso VG; Lake JE; Grinsztejn B
    J Antimicrob Chemother; 2018 Aug; 73(8):2177-2185. PubMed ID: 29722811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.